Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis.

OBJECTIVES: This study was designed to examine the prognostic value of valvuloarterial impedance (Z(va)) in patients with aortic stenosis (AS).

BACKGROUND: We previously showed that the Z(va) is superior to standard indexes of AS severity in estimating the global hemodynamic load faced by the left ventricle (LV) and predicting the occurrence of LV dysfunction. This index is calculated by dividing the estimated LV systolic pressure (systolic arterial pressure + mean transvalvular gradient) by the stroke volume indexed for the body surface area.

METHODS: We retrospectively analyzed the clinical and echocardiographic data of 544 consecutive patients having at least moderate AS (aortic jet velocity > or =2.5 m.s(-1)) and no symptoms at baseline. The primary end point for this study was the overall mortality regardless of the realization of aortic valve replacement (AVR).

RESULTS: Four-year survival was significantly (p < 0.001) lower in the patients with a baseline Z(va) > or =4.5 mm Hg x ml(-1) x m(2) (65 +/- 5%) compared with those with Z(va) between 3.5 and 4.5 mm Hg x ml(-1) x m(2) (78 +/- 4%) and those with Z(va) < or =3.5 mm Hg x ml(-1) x m(2) (88 +/- 3%). The risk of mortality was increased by 2.76-fold in patients with Z(va) > or =4.5 mm Hg x ml(-1) x m(2) and by 2.30-fold in those with a Z(va) between 3.5 and 4.5 mm Hg x ml(-1) x m(2) after adjusting for other risk factors and type of treatment (surgical vs. medical).

CONCLUSIONS: Increased Z(va) is a marker of excessive LV hemodynamic load, and a value >3.5 successfully identifies patients with a poor outcome. These findings suggest that beyond standard indexes of stenosis severity, the consideration of Z(va) may be useful to improve risk stratification and clinical decision making in patients with AS.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app